Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
|
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
|---|---|---|---|---|---|---|---|---|---|
| TGCT | rs6445084 | chr3:172453318 | C/G | 8.14E-5 | 134 | 25.8 | 36.63 | 45.47 | KM Plot |
| TGCT | rs645253 | chr3:172418184 | T/G | 9.93E-5 | 131 | 45.47 | 39.05 | 25.33 | KM Plot |
| TGCT | rs6458297 | chr6:42547891 | C/T | 3.69E-9 | 131 | 19.33 | 51.67 | 37.95 | KM Plot |
| TGCT | rs6469609 | chr8:116905042 | G/C | 7.41E-7 | 134 | 45.7 | 28.7 | 18.83 | KM Plot |
| TGCT | rs6469611 | chr8:116916852 | G/A | 8.4E-7 | 133 | 46.3 | 28.7 | 18.83 | KM Plot |
| TGCT | rs6493 | chr14:78140329 | G/A | 8.03E-5 | 133 | 45.47 | 39.38 | 18.07 | KM Plot |
| TGCT | rs6499785 | chr16:55795214 | C/T | 0.000143 | 134 | 25.8 | 33.53 | 71.72 | KM Plot |
| TGCT | rs6503487 | chr17:42122419 | A/G | 3.88E-8 | 132 | 45.1 | 28.87 | 65.13 | KM Plot |
| TGCT | rs650510 | chr13:21839705 | T/G | 5.93E-7 | 132 | 46.3 | 36.7 | 14.42 | KM Plot |
| TGCT | rs6505693 | chr18:1206140 | G/A | 0.000153 | 131 | 95.23 | 28.53 | 45.83 | KM Plot |
| TGCT | rs6507121 | chr18:32809071 | C/G | 0.000103 | 133 | 17.1 | 35.08 | 48.12 | KM Plot |
| TGCT | rs651165 | chr3:172412887 | G/A | 1.84E-5 | 130 | 45.47 | 37.62 | 24.15 | KM Plot |
| TGCT | rs6545433 | chr2:54817833 | A/G | 5.82E-5 | 132 | 46.3 | 42.27 | 22.42 | KM Plot |
| TGCT | rs658244 | chr13:21850976 | T/C | 6.44E-7 | 132 | 46.3 | 35.73 | 14.42 | KM Plot |
| TGCT | rs658770 | chr13:21849263 | G/A | 6.44E-7 | 132 | 46.3 | 35.73 | 14.42 | KM Plot |